CF ACQUISITION CORP IV-CL A (CFIV) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:CFIV • US12520T1025

10.58 USD
-0.01 (-0.09%)
Last: Dec 7, 2023, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CFIV. CFIV was compared to 0 industry peers in the Unkown industry. CFIV has a bad profitability rating. Also its financial health evaluation is rather negative. CFIV has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year CFIV has reported negative net income.
  • CFIV had a negative operating cash flow in the past year.
CFIV Yearly Net Income VS EBIT VS OCF VS FCFCFIV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 0 5M -5M 10M

1.2 Ratios

Industry RankSector Rank
ROA -3.06%
ROE -3.51%
ROIC N/A
ROA(3y)3.71%
ROA(5y)N/A
ROE(3y)3.99%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CFIV Yearly ROA, ROE, ROICCFIV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 0 2 4 6 8 10

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for CFIV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CFIV Yearly Profit, Operating, Gross MarginsCFIV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, CFIV has less shares outstanding
  • Compared to 1 year ago, CFIV has a worse debt to assets ratio.
CFIV Yearly Shares OutstandingCFIV Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 20M 40M 60M
CFIV Yearly Total Debt VS Total AssetsCFIV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 100M 200M 300M 400M 500M

2.2 Solvency

  • An Altman-Z score of 12.65 indicates that CFIV is not in any danger for bankruptcy at the moment.
  • A Debt/Equity ratio of 0.09 indicates that CFIV is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z 12.65
ROIC/WACCN/A
WACCN/A
CFIV Yearly LT Debt VS Equity VS FCFCFIV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 100M 200M 300M 400M

2.3 Liquidity

  • CFIV has a Current Ratio of 0.04. This is a bad value and indicates that CFIV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • A Quick Ratio of 0.04 indicates that CFIV may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.04
CFIV Yearly Current Assets VS Current LiabilitesCFIV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 1M 2M 3M 4M 5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • CFIV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -142.31%.
EPS 1Y (TTM)-142.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CFIV. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CFIV Price Earnings VS Forward Price EarningsCFIV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CFIV Per share dataCFIV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • CFIV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

CF ACQUISITION CORP IV-CL A

NASDAQ:CFIV (12/7/2023, 8:00:00 PM)

10.58

-0.01 (-0.09%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.51%
Inst Owner Change0%
Ins Owners63.5%
Ins Owner Change0%
Market Cap222.71M
Revenue(TTM)N/A
Net Income(TTM)-2.48M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.15
P/tB 3.15
EV/EBITDA N/A
EPS(TTM)-0.11
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS3.36
TBVpS3.36
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.06%
ROE -3.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)3.71%
ROA(5y)N/A
ROE(3y)3.99%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.04
Quick Ratio 0.04
Altman-Z 12.65
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-142.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

CF ACQUISITION CORP IV-CL A / CFIV FAQ

What is the fundamental rating for CFIV stock?

ChartMill assigns a fundamental rating of 1 / 10 to CFIV.


What is the valuation status for CFIV stock?

ChartMill assigns a valuation rating of 0 / 10 to CF ACQUISITION CORP IV-CL A (CFIV). This can be considered as Overvalued.


Can you provide the profitability details for CF ACQUISITION CORP IV-CL A?

CF ACQUISITION CORP IV-CL A (CFIV) has a profitability rating of 0 / 10.


Can you provide the financial health for CFIV stock?

The financial health rating of CF ACQUISITION CORP IV-CL A (CFIV) is 2 / 10.